These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6128021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma timolol levels and systolic time intervals.
    Singh BN, Williams FM, Whitlock RM, Collett J, Chew C.
    Clin Pharmacol Ther; 1980 Aug; 28(2):159-66. PubMed ID: 7398183
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transdermal timolol: beta blockade and plasma concentrations after application for 48 hours and 7 days.
    McCrea JB, Vlasses PH, Franz TJ, Zeoli L.
    Pharmacotherapy; 1990 Aug; 10(4):289-93. PubMed ID: 2388875
    [Abstract] [Full Text] [Related]

  • 7. Initial evaluation of transdermal timolol: serum concentrations and beta-blockade.
    Vlasses PH, Ribeiro LG, Rotmensch HH, Bondi JV, Loper AE, Hichens M, Dunlay MC, Ferguson RK.
    J Cardiovasc Pharmacol; 1985 Aug; 7(2):245-50. PubMed ID: 2581075
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH, Deering AH, Scott MG, Harron DW, Shanks RG.
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A, Tawara K, Oka T, Ofuji T, Kawahara K.
    Eur J Clin Pharmacol; 1982 Apr; 23(3):189-95. PubMed ID: 6129139
    [Abstract] [Full Text] [Related]

  • 14. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade.
    Wilson TW, Firor WB, Johnson GE, Holmes GI, Tsianco MC, Huber PB, Davies RO.
    Clin Pharmacol Ther; 1982 Dec; 32(6):676-85. PubMed ID: 7140133
    [Abstract] [Full Text] [Related]

  • 15. Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.
    Thuillez C, Richer C, Duhazé P, Bergougnan L, Giudicelli JF.
    Eur J Clin Pharmacol; 1985 Dec; 29(4):405-11. PubMed ID: 3912184
    [Abstract] [Full Text] [Related]

  • 16. Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug.
    Balnave K, Neill JD, Russell CJ, Harron DW, Leahey WJ, Wilson R, Shanks RG.
    Br J Clin Pharmacol; 1981 Feb; 11(2):171-80. PubMed ID: 6111331
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH, Thadani U, Davidson C, singleton W, Myint S.
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [Abstract] [Full Text] [Related]

  • 20. Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension.
    von Bahr C, Collste P, Frisk-Holmberg M, Haglund K, Jorfelt L, Orme M, Ostman J, Sjoqvist F.
    Clin Pharmacol Ther; 1976 Aug; 20(2):130-7. PubMed ID: 7373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.